Two teams of CIRM-funded researchers are working toward what they hope will be a functional cure for HIV infection.
These groups are the focus of our initial annual report story, which you can read here. That story quotes CIRM governing board member Jeff Sheehy, who is a long-time HIV/AIDS advocate:
“I’m incredibly optimistic. I don’t think we’re going to get there tomorrow, but I think the train has left the station to get there. The whole dialog has been completely upended, and CIRM has been at the cutting edge.”
Throughout the next weeks we will be previewing our online annual report stories here. They cover promising science, patient stories, and CIRM initiatives that will help accelerate the development of the therapies those patients are waiting on.
We’re doing the annual report a little differently this year. In the past, we printed and mailed annual report books. (You can download PDFs of those books here.) This year we’re saving money and instead printing smaller brochures with some financial data and excerpts of the full news and patient stories that can be found online. Those brochures will be available for download, and in hard copy at our meetings, in the next few weeks.
Taken together, the stories in this year’s annual report show the many ways in which California is leading in the development of new stem cell-based therapies, in initiatives to speed those therapies, and in the involvement of patient advocates to help us achieve our mission.
As Paula Cannon, who is one of the HIV/AIDS researchers who appears in today’s featured story, says:
“This could only happen in California.”
I hope you find the stories interesting, informative and inspiring.